# B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme

> **NCT05474378** · PHASE1 · RECRUITING · sponsor: **Stanford University** · enrollment: 39 (estimated)

## Conditions studied

- Brain and Nervous System

## Interventions

- **DRUG:** B7-H3CART

## Key facts

- **NCT ID:** NCT05474378
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-12
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05474378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05474378, "B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05474378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*